Burning Rock Biotech Ltd. (BNR)
9.75
-0.05
(-0.51%)
USD |
NASDAQ |
Aug 26, 16:00
9.75
0.00 (0.00%)
After-Hours: 19:28
Burning Rock Biotech Shareholders Equity (Quarterly) : 74.76M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 74.76M |
| December 31, 2025 | 76.60M |
| September 30, 2025 | 77.20M |
| June 30, 2025 | 78.74M |
| March 31, 2025 | 78.85M |
| December 31, 2024 | 79.57M |
| September 30, 2024 | 92.38M |
| June 30, 2024 | 93.29M |
| March 31, 2024 | 99.18M |
| December 31, 2023 | 108.35M |
| September 30, 2023 | 118.15M |
| June 30, 2023 | 133.20M |
| March 31, 2023 | 152.15M |
| December 31, 2022 | 166.63M |
| September 30, 2022 | 183.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 213.95M |
| March 31, 2022 | 260.85M |
| December 31, 2021 | 289.54M |
| September 30, 2021 | 318.96M |
| June 30, 2021 | 336.37M |
| March 31, 2021 | 356.02M |
| December 31, 2020 | 370.20M |
| September 30, 2020 | 371.85M |
| June 30, 2020 | 379.25M |
| March 31, 2020 | 125.23M |
| December 31, 2019 | 91.24M |
| September 30, 2019 | 99.28M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -1.070M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| CareDx, Inc. | 425.60M |
| Natera, Inc. | 1.821B |
| Exagen, Inc. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.04M |
| Total Liabilities (Quarterly) | 39.28M |
| Debt to Equity Ratio | 0.0985 |
| Current Ratio | 3.050 |
| Net Debt Paydown Yield | -0.03% |